Complete turn-key solution for the judicious clinical laboratory owner.

TOXICOLOGY - Testing for Drugs of Abuse

Identifying Standard and Emerging Drugs in Clinical Samples (Urine or Oral Fluid)

OUR UNIQUE VALUE TO EACH CLIENT

*

METHODS TO DETECT NEW EMERGING DRUGS

Many drugs such as Carfentanyl, Kava Kratom, and various forms of synthetic marijuana like K2, Spice, Bath Salts, AK-47, and 24 Karat Gold are difficult to detect. Medical Source and our strategic partners in the academic, state, and commercial marketplace remain vigilant to incorporate methods for their identification into your clinical laboratory.

URINE DRUG TESTING provides objective information to identify the presence or absence of drugs or drug classes in the body and assists in making treatment decisions.

Specimen Validity Testing - to ensure the sample is consistent with normal human urine and has not been adulterated or substituted; may include pH, specific gravity, oxidants, and creatinine.

Presumptive / Qualitative Drug Testing - to determine the presence or absence of drugs or drug classes in a human sample; results are expressed as negative, positive, or as a numerical result.

Definitive / Quantitative Drug Testing - to identify specific medications, illicit substances, and metabolites; reports the results of drugs absent or present in concentrations of ng/ml; payment is limited to LC/MS methodology.

PGx Pharmacogenomic - Real Time DNA Testing for Drug Metabolism

Drug efficacy and toxicity vary substantially across individuals.

Drugs and dosages are typically adjusted by trial and error. The clinical consequences include prolonged time to optimal therapy and/or adverse drug reactions, which account for the injury or death of more than 770,000 people each year.

PGx (Pharmacogenomic testing) presents a solution to reduce health care costs associated with ADRs and poor response to pharmacotherapy. The patient’s genetic makeup in combination with other clinical information creates a personalized medication regimen with greater efficacy and safety. Most prescribed medications have genetic data to support appropriate dosing or selection, as these analyses are routinely performed during drug development.

CARDIOLOGY PROFILE

* APOE - CYP1A2 - CYP2C19 - CYP2C9 - CYP2D6 - CYP3A4 - CYP3A5 - Factor II - Factor V - MTHFR - SLC01B1 - VKORC1 *

ONCOLOGY PROFILE

* CYP2D6 - CYP3A4 - DPYD - MTHFR - SLC01B1 - TPMT *

PAIN PROFILE

* CYP1A2 - CYP2C19 - CYP2C9 - CYP2D6 - CYP3A4 - CYP3A5 - MTHFR *

PSYCHIATRY PROFILE

* CYP2D6 -  CYP2C19 - CYP1A2  -  CYP2C9 - MTHFR - TPMT- CYP3A4 - CYP3A5 *

CGx Cancer Genomics - Inherited (Hereditary) Cancer

DNA – Inherited (Hereditary) Cancer Testing provides physicians the ability to refine a patient’s cancer risk through an analysis of inherited mutations. Approximately 5 to 10 percent of cancers are thought to be caused by mutations in genes associated with hereditary cancer syndromes.  Providing pertinent information about cancer risk is important to a patient’s understanding and ability to make informed decisions regarding their healthcare.

BREAST PROFILE

* BRCA1 - BRCA2 -TP53 - PTEN - STK11 - CDH1 - PALB2 - CHEK2 - ATM - NBN - BARD1 - BRIP1 *

OVARIAN PROFILE

* BRCA1 - BRCA2 - MLH1 - MSH2 - MSH6 - PMS2 - EPCAM - TP53 - STK11 - PALB2 - BARD1 - BRIP1 - RAD51C - RAD51D *

UTERINE PROFILE

* MLH1 - MSH2 - MSH6 -  PMS2 - EPCAM - TP53 - PTEN - STK11 *

COLORECTAL PROFILE

* MLH1 - MSH2 - MSH6 -  PMS2 - EPCAM - APC - MUTYH - TP53 - PTEN - STK11 - BMPR1A - SMAD4 - PALB2 - ATM *

PANCREATIC PROFILE

* CHEK2 -  BRCA1 - BRCA2 - MLH1 - MSH2 - EPCAM - APC - CDKN2A - TP53 - STK11 - BMPR1A - SMAD4 - PALB2 - ATM *

LYNCH SYNDROME PROFILE

* MLH1 - MSH2 - MSH6 -  PMS2 - EPCAM *

Comprehensive Wellness Panel

The medical necessity to run an annual comprehensive wellness panel to determine the general health status of each patient is now a reality.

Our comprehensive wellness panel includes an assessment of anemia, organ & metabolic function, diabetes & endocrine wellness, cardiac risk, inflammation, cancer, bone & joint, COPD, nutritional status, allergic disease, hormone status, and infectious disease.

Cannabis Testing Laboratory

Medical Source offers a portfolio of solutions dynamic enough to meet ever - changing state requirements, while generating cost efficient, exceptional quality data mandated in the 2019 standards.

Click the link below to go to our cannabis testing page.

https://consultants-lab.com/cannabis-testing/